Hongkong Chinese Limited Overview
Hongkong Chinese Limited is an investment holding company within the Riady family's Lippo Group. In economic terms it is a listed, leveraged holding vehicle for an indirect interest in Singapore-listed OUE Limited. HKC holds 50% of Lippo ASM Asia Property Limited (LAAPL). LAAPL owns about 92.05% of Fortune Crane Limited, which in turn controls about 73.44% of OUE. That gives HKC a derived look-through economic interest in OUE of roughly 33.8%. OUE is a Singapore real-estate, hospitality and healthcare group that controls OUE REIT, OUE Healthcare and a large stake in First REIT. The rest of HKC is small: a sliver of Hong Kong investment property, unsold units at Lippo Plaza Beijing, a Singapore development associate, treasury and securities positions, and project-management services. HKC carried HK$8.1bn in LAAPL at 30 June 2026 against a market value of about HK$0.76bn. Its reported results are therefore driven almost entirely by non-cash equity-accounted swings at OUE, especially OUE's exposure to the Chinese Mainland property market through Gemdale Properties and Investment.
The company's own description
The FY2025 Annual Report describes HKC as an investment holding company. Its subsidiaries, associates and joint ventures are engaged in investment holding, property investment, property development, hotel operation, healthcare services, project management, securities investment and treasury investment. The report states that the nature of these activities did not change materially during FY2025.
The company's stated business strategy is short. HKC describes its activities as diversified and says it aims for long-term sustainable growth that preserves and enhances shareholder value. It says it does this by selecting attractive investment opportunities to strengthen and extend its business scope while keeping financial management prudent and disciplined (FY2025 Annual Report, "Business Strategy").
Independent characterisation
HKC is better described as a closed-end, single-asset holding company than as an operating business. Three facts support this.
-
Asset concentration. At 30 June 2026, interests in joint ventures were HK$8,306.5m out of total assets of HK$8,748.1m, or 95.0% (derived). Of this, HK$8,144.7m was the Group's total interest in LAAPL (1H2026 Interim Results, Notes 2 and 7).
-
Revenue is mostly intra-group interest. FY2025 revenue was HK$53m. The property investment segment contributed 93% of it. That segment revenue consists mainly of interest on shareholder loans to the LAAPL group plus a small amount of rental income. In FY2025 the largest single customer accounted for 62% of revenue and the five largest for 84% (FY2025 AR, "Major Suppliers and Customers"). Given the loan structure, the largest customer is almost certainly the LAAPL group/Fortune Crane, although the report does not name it.
-
Earnings are mostly equity-accounted. Between FY2021 and FY2025, "Earnings from equity investments" ranged from +HK$651.5m to −HK$1,197m. Operating income ranged only from HK$15m to HK$40m (StockAnalysis/S&P GMI).
Revenue model mix
| Revenue type (1H2026) | HKD Mn | % of total | Notes |
|---|---|---|---|
| Interest income (loans/advances and other) | 11.88 | 76.5 | 1H2025: 33.72. Fell after partial interest waiver on JV loans from 1 Jul 2025 |
| Property rental income (operating leases) | 3.41 | 21.9 | 1H2025: 3.59 |
| Project management services (contracts with customers, Singapore) | 0.22 | 1.4 | 1H2025: 0.21 |
| Dividend income | 0.02 | 0.2 | Unchanged |
| Other | 0.00 | 0.0 | — |
| Total | 15.53 | 100.0 | 1H2025: 37.55 |
Source: 1H2026 Interim Results, Note 3.
There is no product sales, subscription or licensing revenue. Only about 1–2% of revenue is "revenue from contracts with customers" under HKFRS 15.
Value-chain position, customers and end-markets
Value-chain position: a capital provider and owner. HKC supplies equity and shareholder loans to the LAAPL/OUE structure and does not run operations itself.
Customer types: mainly related-party borrowers (JV entities). The other customers are commercial tenants of HK investment property and a Singapore client for project management.
End-markets reached through OUE: - Singapore Grade A office (OUE Bayfront, One Raffles Place, OUE Downtown Office)
-
Singapore hospitality (Hilton Singapore Orchard, Crowne Plaza Changi Airport) and retail (Mandarin Gallery)
-
Sydney office (19.9% of Salesforce Tower, from March 2026)
-
Asian healthcare (OUE Healthcare in Singapore, Chinese Mainland and Myanmar; First REIT in Singapore, Japan and Indonesia)
-
Chinese Mainland property, through OUE's 29.07% stake in Gemdale Properties and Investment (GPI)
Direct end-markets: Hong Kong property leasing (small), Beijing strata residential/commercial (Lippo Plaza remainders), and Singapore project management.
Strategy
Stated strategy (FY2025 Annual Report themes, paraphrased)
Diversified investment holding: The Group describes its business activities as diversified.
Long-term sustainable growth: that preserves and enhances shareholder value.
Selective investment: Choose attractive opportunities that strengthen and extend business scope.
Prudent, disciplined financial management: Repeated in the FY2025 and 1H2026 prospects sections as cautious management of assets and prudent capital management.
Chairman's message: Navigate tariff and geopolitical headwinds "with resilience and determination" (FY2025 Chairman's Statement), and exercise prudence in capital and expenditure management given the Middle East conflict.
No investor day is held. No medium-term financial targets or guidance are published (not publicly disclosed).
Strategic initiatives, last 24 months
| Date | Initiative | Level | Status / significance |
|---|---|---|---|
| 27 Dec 2024 → 2025 | Lippo Limited distribution in specie of HKC shares; Lippo Capital becomes direct holder | Shareholder | Completed by 31 Dec 2025. Raised the public float and simplified the chain |
| Sep 2025 | Lippo Limited privatised and delisted; Lippo becomes a "former holding company" | Group | Completed (scheme effective 23 Sep 2025) |
| From 1 Jul 2025 | Pro-rata cessation of interest on part of the shareholder loans to FCL (approx. S$312.41m waived from HKC side) | HKC / JV | Cuts HKC revenue but also reduces JV losses. Group-neutral and a cash-relief measure for the JV |
| Dec 2025 | Governance refresh: Workforce Diversity Policy adopted; Audit and Nomination Committee terms of reference revised; Shareholders' Communication Policy revised | HKC | Implemented |
| Mar 2026 | Dividend Policy revised; Anti-corruption Policy revised | HKC | Implemented. Policy says no fixed payout ratio |
| Jun 2026 | Re-domiciliation from Bermuda to Hong Kong approved by shareholders | HKC | Pending other conditions. Rationale: lower cost and simpler administration |
| May 2025 → 2028 | Hotel Indigo Changi Airport (255 rooms, OUE 51%), Singapore's first zero-energy hotel | OUE | Under construction |
| Dec 2025 | OUE buys an additional 19.32% of OUEH (to 89.68%) | OUE | Completed |
| Mar 2026 | OUE REIT acquires 19.9% of Salesforce Tower, Sydney | OUE REIT | Completed; first entry into Australia |
| Jun 2026 | Proposed sale of Crowne Plaza Changi Airport by OUE REIT to an OUE JV | OUE / OUE REIT | Subject to unitholder EGM |
| Jun 2026 | First REIT phase-one divestment of 8 Indonesian hospitals | First REIT | Unitholder-approved; buyer approval pending |
| 24 Aug 2026 | Proposed privatisation of OUEH at S$0.050 per share by scheme of arrangement | OUE | Pending |
Sustainability / ESG commitments
At HKC level: an Environmental Policy, an ESG Report (FY2025 AR pp.40–78), ESG risks integrated into ERM since 2018, and the Workforce Diversity Policy (Dec 2025). At OUE level: Green Mark upgrades for four OUE REIT assets in 2025, Singapore Sustainability Awards for CPCA and Hilton Singapore Orchard, and the zero-energy Hotel Indigo. No quantified emissions targets were retrieved for HKC.
Cost programmes / guidance
No formal cost programme or financial guidance has been published. Unallocated corporate expenses fell to HK$9.6m in 1H2026 from HK$10.6m in 1H2025.
Products & Services
HKC has no consumer "products". Its catalogue is a portfolio of assets and investee businesses. They are listed below by segment and then by the look-through holdings that drive value.
Direct holdings
| Segment | Asset / offering | Description | Customer / counterparty | Latest status | Pricing model |
|---|---|---|---|---|---|
| Property investment | Investment properties (HK$123.7m at 30 Jun 2026) | Leased commercial property | Commercial tenants | Rental income HK$3.4m in 1H2026 | Operating leases |
| Property investment | Shareholder loans to Fortune Crane Limited | S$380.42m (approx. HK$2,303m) outstanding at 31 Dec 2025, unsecured and repayable on demand; 2.25% p.a. but interest waived on approx. S$312.41m from 1 Jul 2025 | LAAPL group | Interest income from loans HK$11.4m in 1H2026 vs HK$31.2m in 1H2025 | Contractual interest |
| Property development | Lippo Plaza, Beijing (remaining units) | Unsold properties held for sale (HK$67.0m) and properties under development (HK$20.6m) | Retail buyers in Beijing | Sales described as stagnant | Unit sales |
| Property development | Associate: developer of Marina Collection, Sentosa (Singapore) | Associate that developed and sold flats; defendant in UOB litigation | — | Carrying value fell from HK$237.8m to HK$113.0m after the Aug 2026 judgment | — |
| Property development (FY2025) | Associate carrying an office-leasing business | Impairment provision taken in FY2025 | — | Name not disclosed in retrieved extracts | — |
| Treasury investment | Money-market deposits | Cash and deposits | Banks | Interest income HK$0.49m in 1H2026 | Deposit interest |
| Securities investment | Listed equities and other financial assets | FVTPL HK$2.5m current plus HK$3.0m non-current; FVOCI HK$0.06m | Market | FV loss HK$0.53m in 1H2026 | Market price |
| Other | Project management services | Services delivered in Singapore, recognised over time | One client in Singapore | HK$0.22m in 1H2026 | Fee-based |
Look-through portfolio via LAAPL → OUE Limited (principal value driver)
| Business (OUE Group) | Key assets / brands | Description and recent status | Source |
|---|---|---|---|
| OUE REIT (approx. 49.92% LAAPL group interest, Jun 2026) | OUE Bayfront; One Raffles Place; OUE Downtown Office; Hilton Singapore Orchard; Mandarin Gallery; Crowne Plaza Changi Airport; 19.9% of Salesforce Tower, Sydney | Office committed occupancy 95.4% and Mandarin Gallery 95.7% at 31 Dec 2025. Salesforce Tower stake completed Mar 2026 (100% committed occupancy at 30 Jun 2026). Green Mark Platinum for OUE Bayfront and OUE Downtown Office. Proposed sale of Crowne Plaza Changi Airport to an OUE JV announced Jun 2026, subject to unitholder approval | FY2025 AR; 1H2026 IR |
| Hospitality | Crowne Plaza Changi Airport; Hilton Singapore Orchard; Hotel Indigo Changi Airport (255 rooms, OUE 51%) | CPCA named "World's Best Airport Hotel" at the 2025 Skytrax awards for the 10th straight year. Hotel Indigo Changi Airport at Terminal 2, construction began May 2025, completion targeted 2028; billed as Singapore's first zero-energy hotel | FY2025 AR |
| OUE Healthcare (OUEH; 89.68%) | O2 Healthcare Group ("Lung Centre", Singapore); O2 SleepWell Laboratory (Mar 2026); hospital in Wuxi; Prince Bay Hospital, Shenzhen (JV, opened Jul 2026); three hospitals in Mandalay, Myanmar (JVs) | OUE raised its stake by 19.32% in Dec 2025. Privatisation scheme at S$0.050 per share announced 24 Aug 2026 | FY2025 AR; 1H2026 IR |
| First REIT (approx. 45.81%) | 3 properties in Singapore, 14 in Japan, 14 in Indonesia (healthcare real estate) | Phase-one sale of 8 Indonesian assets approved by unitholders Jun 2026, pending buyer-side approval | 1H2026 IR |
| GPI (29.07%, equity-accounted) | Gemdale Properties and Investment, a Chinese Mainland property company | Main source of OUE's losses and impairments in FY2024–1H2026 | OUE FY2025 profit guidance; OUE 1H2026 results |
Financial Narrative
Income statement
Notes:
-
EPS is net income divided by 1,998.28m shares; S&P shows HK$0.34 / 0.24 / 0.08 / −0.60 / −0.45.
-
No interim or final dividend for FY2024 or FY2025 (FY2025 AR). The FY2023 final dividend was paid in 2024 (2025 Interim Report, statement of changes in equity).
Revenue CAGR FY2021–FY2025 (derived): (53.19 / 81.09)^(1/4) − 1 = −10.0% per year.
Interim bridge.
Sources: 1H2025 Interim Report; Reuters/Tiger brief (29 Sep 2025); 1H2026 Interim Results.
Implied 2H2025 attributable loss (derived) = −891.65 − 199.47 = −HK$1,091m. Trailing twelve months to June 2026 = −HK$1,661m (S&P TTM).
Commentary.
Inflection: FY2023 was the last profitable year. Over FY2021–FY2023 the share of investee profits fell from HK$651.5m to HK$174.8m. In FY2024–FY2025 it turned sharply negative, as OUE took Chinese Mainland property losses through GPI, fair-value losses on investment property, and impairments.
FY2024 EBIT spike: operating income rose to HK$39.6m, an operating margin of 54%. The main cause was lower SG&A (HK$17.4m vs HK$34.4m in FY2023), on S&P's classification.
FY2025 revenue drop of 27%: interest income fell after the shareholders of a JV agreed to stop accruing interest on part of their shareholder loans pro rata from 1 July 2025 (FY2025 AR). The effect is economically neutral at group level, because HKC's share of JV losses falls correspondingly. Reported revenue, however, declines.
Finance costs: fell to HK$23m in FY2025 from HK$32m, on lower HIBOR (FY2025 AR). They were HK$10.9m in 1H2026.
Staff costs: rose to HK$18m in FY2025 from HK$11m (FY2025 AR), even though headcount was flat at 23. This partly reflects discretionary bonuses to the Chairman (HK$3.09m) and the CEO (HK$1.04m).
Balance sheet
Latest position (30 June 2026, HK$ m):
-
Total assets 8,748.1, of which interests in JVs 8,306.5 and associates 113.0
-
Cash 84.7; bank loans 506.7 (all non-current, HKD, floating rate); total liabilities 564.8
-
Equity attributable 8,167.7; NAV per share HK$4.1
-
Current ratio 3.8; gearing (borrowings / attributable equity) 6.2%
-
No charges on assets, no material contingent liabilities, and no capital commitments
Source: 1H2026 Interim Results.
Cash flow
Source: S&P GMI via StockAnalysis. No buybacks were made in FY2025 or 1H2026 (FY2025 AR; 1H2026 IR).
Commentary. Cash generation is structurally thin. HKC receives no dividends of note from LAAPL in the cash-flow data, and the interest it receives is now partly waived. In FY2022–FY2024 the company funded negative operating cash flow and dividends by drawing down bank debt, which rose from HK$273m to HK$501m. FY2025 operating cash flow turned positive at HK$31.7m. S&P does not break out the reason; plausible drivers are timing of interest receipts and working capital. FY2024 shows a HK$536m bank-loan refinancing: HK$501m was repaid and HK$536m newly drawn.
Ratios
Methodology:
-
ROE and ROA use the average of opening and closing balances for FY2022–FY2025.
-
The company reports a current ratio of 3.9 (FY2025) and 3.6 (FY2024), and gearing of 5.8% and 5.6%, which agree with the derived figures.
-
ROIC: S&P shows −0.06% on a TTM basis.
-
Cash conversion cycle: not meaningful. HKC has no trade receivables or payables of significance, and its "inventory" (properties held for sale) does not turn over.
Interpretation. Leverage at the HKC level is low, at about 6% gearing. However, interest is not covered by recurring operating earnings: EBIT/interest was 0.66x in FY2025 and negative on a TTM basis per S&P (−0.24x). Debt service relies on the cash buffer (HK$85–111m), on the interest still being received from the JV, and on the ability to refinance. The look-through leverage is materially higher. OUE reported net gearing of 53.8% at 31 December 2025 (The Edge Singapore), and LAAPL bank facilities are secured on listed shares it holds (1H2026 IR, Note 7).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products / services | Carries share of results of |
|---|---|---|---|
Property investment | Letting and resale of properties; interest on loans to JVs | Rental of HK/other investment property; JV shareholder-loan interest | Joint ventures (LAAPL → OUE) |
Property development | Development and sale of properties | Remaining strata units at Lippo Plaza, Beijing | Associates (incl. the Singapore Marina Collection associate) |
Treasury investment | Money-market investments | Bank deposits / money-market interest | — |
Securities investment | Securities held for trading and long-term strategic purposes | Listed equities / debt securities | — |
Other | Mainly project management services | Project management (Singapore client) | — |
Revenue by Segment
| Segment | FY2024 | FY2025 |
|---|---|---|
Property investment revenue (HKD Mn) | 70 | 50 |
All other segments combined revenue (HKD Mn, derived) | 2.85 | 3.19 |
Total revenue (HKD Mn) | 72.85 | 53.19 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment profit before share of JV/associates
| Segment profit before share of JV/associates | FY2024 | FY2025 |
|---|---|---|
Property investment segment profit (HKD Mn) | 28 | 6 |
Property development segment result (HKD Mn) | -4 | -4 |
Revenue by Segment (1H2025–1H2026)
| Segment (external revenue, HKD Mn) | 1H2025 | 1H2026 |
|---|---|---|
Property investment | 34.75 | 14.53 |
Property development | 0 | 0 |
Treasury investment | 2.55 | 0.49 |
Securities investment | 0.02 | 0.02 |
Other | 0.22 | 0.48 |
Total | 37.55 | 15.53 |
Revenue by Segment and Revenue by Segment (%)
| Segment results (HKD Mn) | 1H2025 | 1H2026 |
|---|---|---|
Property investment | 19.41 | 0.23 |
Property development | -1.74 | -1.67 |
Treasury investment | 2.55 | 0.49 |
Securities investment | 0.66 | -0.64 |
Other | -0.22 | 0.26 |
Total segment results | 20.66 | -1.33 |
Unallocated corporate expenses | -10.58 | -9.62 |
Share of associates (in property development) | 2.91 | -126.33 |
Share of joint ventures (in property investment) | 189.10 | -432.10 |
Profit/(loss) before tax | 202.09 | -569.37 |
Segment assets (HKD Mn)
| Segment assets (HKD Mn) | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Property investment (ex-JV) | 147.91 | 151.07 |
Property development (ex-associates) | 73.98 | 75.72 |
Treasury investment | 99.62 | 72.19 |
Securities investment | 6.01 | 5.48 |
Other | 8.53 | 9.85 |
Interests in associates | 237.81 | 113.03 |
Interests in joint ventures | 8,722.59 | 8,306.50 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 81.09 | 71.77 | 74.79 | 72.85 | 53.19 |
Revenue growth (%) | -26.30 | -11.49 | 4.21 | -2.61 | -26.99 |
Gross profit (HKD Mn) | 77.39 | 70.93 | 71.91 | 70.61 | 51.17 |
Operating income / EBIT (HKD Mn) | 18.84 | 17.10 | 18.63 | 39.59 | 15.19 |
EBITDA (HKD Mn) | 24.73 | 22.77 | 24.74 | 40.73 | 16.47 |
Interest expense (HKD Mn) | 12.17 | 11.10 | 26.56 | 32.22 | 23.12 |
Share of equity investees (HKD Mn) | 651.50 | 470.69 | 174.77 | -1,197.00 | -871.94 |
Pre-tax income (HKD Mn) | 654.19 | 491.22 | 158.99 | -1,194.00 | -891.84 |
Net income attributable (HKD Mn) | 670.30 | 488.77 | 157.12 | -1,200.00 | -891.65 |
EPS basic = diluted (HK cents, derived) | 33.5 | 24.5 | 7.9 | -60.1 | -44.6 |
Dividend per share (HK cents, S&P) | 1.3 | 1.0 | 1.0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin metric (%)
| Margin metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin | 95.44 | 98.82 | 96.15 | 96.92 | 96.20 |
Operating margin | 23.24 | 23.83 | 24.91 | 54.34 | 28.56 |
EBITDA margin | 30.49 | 31.73 | 33.07 | 55.92 | 30.96 |
Net margin | 826.62 | 680.99 | 210.07 | -1,647.19 | -1,676.47 |
Income Statement and Margin Analysis (%) (1H2024–1H2026)
| Metric (HKD Mn) | 1H2024 | 1H2025 | 1H2026 |
|---|---|---|---|
Revenue | 36.20 | 37.55 | 15.53 |
Share of JVs | -432.68 | 189.10 | -432.10 |
Share of associates | 10.02 | 2.91 | -126.33 |
Profit/(loss) attributable | -421.60 | 199.47 | -569.49 |
EPS (HK cents) | -21.1 | 10.0 | -28.5 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 11,570 | 11,221 | 11,158 | 9,545 | 9,311 |
Long-term investments, mainly JV/associates (HKD Mn) | 11,159 | 10,765 | 10,780 | 9,226 | 8,963 |
Cash and equivalents (HKD Mn) | 122.21 | 207.37 | 145.46 | 97.33 | 110.93 |
Short-term debt incl. current leases (HKD Mn) | 0.25 | 0.27 | 0.27 | 0 | 0 |
Long-term debt (HKD Mn) | 272.56 | 456.11 | 465.67 | 501.47 | 505.07 |
Total debt (HKD Mn) | 272.81 | 456.64 | 465.94 | 501.47 | 505.07 |
Net debt (HKD Mn, S&P, net of cash and ST investments) | 139.91 | 248.96 | 320.25 | 404.08 | 391.14 |
Total liabilities (HKD Mn) | 349.42 | 522.96 | 529.09 | 563.30 | 568.46 |
Equity attributable to shareholders (HKD Mn) | 11,201 | 10,680 | 10,613 | 8,967 | 8,727 |
Total equity incl. NCI (HKD Mn) | 11,221 | 10,698 | 10,629 | 8,982 | 8,742 |
Goodwill and intangibles (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital (HKD Mn) | 181.29 | 249.99 | 186.19 | 133.54 | 155.04 |
Book value per share (HKD) | 5.61 | 5.34 | 5.31 | 4.49 | 4.37 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | 13.26 | -33.83 | -42.42 | -27.01 | 31.66 |
Capital expenditure (HKD Mn, outflow) | 0.54 | 0.76 | 1.76 | 2.84 | 0.17 |
Free cash flow (HKD Mn) | 12.72 | -34.59 | -44.17 | -29.86 | 31.49 |
Common dividends paid (HKD Mn) | 34.97 | 44.96 | 0 | 19.98 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net debt issued / (repaid) (HKD Mn) | 4.74 | 179.75 | 5.74 | 34.74 | 10.00 |
Cash interest paid (HKD Mn) | 20.03 | 7.44 | 22.83 | 31.61 | 29.53 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%, derived) | 6.0 | 4.5 | 1.5 | -12.3 | -10.1 |
ROA (%, derived) | 5.8 | 4.3 | 1.4 | -11.6 | -9.5 |
Current ratio (x, derived) | 3.96 | 5.69 | 4.58 | 3.62 | 3.90 |
Debt / total equity (%, derived) | 2.4 | 4.3 | 4.4 | 5.6 | 5.8 |
Net debt / EBITDA (x, derived) | 5.7 | 10.9 | 12.9 | 9.9 | 23.7 |
Interest coverage EBIT / interest (x, derived) | 1.55 | 1.54 | 0.70 | 1.23 | 0.66 |
Asset turnover (x, derived) | 0.007 | 0.006 | 0.007 | 0.007 | 0.006 |
Revenue by Region
| Geographic market (HKD Mn) | 1H2025 | 1H2026 |
|---|---|---|
Republic of Singapore — project management revenue | 0.212 | 0.220 |
Revenue stream
| Revenue stream | Economic geography | FY2025 materiality | Trend | Driver |
|---|---|---|---|---|
Interest on loans to LAAPL/FCL | Singapore (borrower is a Singapore-centred JV; loans are SGD) | Dominant (~60–85% of revenue) | Declining sharply | Interest waiver on approx. S$312m of loans from 1 Jul 2025 |
Rental income | — | approx. HK$7m p.a. (1H2026 run-rate 3.4m) | Slightly declining | Leasing market |
Lippo Plaza Beijing sales | Chinese Mainland | Nil sales recognised | Stagnant | Prolonged Mainland property correction |
Treasury interest | Hong Kong | Small | Declining | Lower cash balances and rates |
Project management | Singapore | approx. HK$0.4m p.a. | Stable | Single client |
Valuation Snapshot
| Metric | Value | Date / source |
|---|---|---|
Last price | HK$0.38 | Close 9 Oct 2026 (S&P via StockAnalysis) |
Recent reference prices | HK$0.455 (31 Jul 2026); HK$0.45 (18 Aug 2026) | StockAnalysis |
52-week change | +15.15% | S&P, as of 10 Oct 2026 |
50-day / 200-day moving average | HK$0.43 / HK$0.36 | S&P |
Beta (5-year) | 0.45 | S&P |
20-day average volume | approx. 402,484 shares | S&P |
Market capitalisation | approx. HK$759m | S&P |
Enterprise value | approx. HK$1.19bn | S&P |
Valuation Multiples
| Multiple | 0655.HK | Comment |
|---|---|---|
P/E (TTM) | n/m | Loss-making (TTM loss HK$1,661m) |
EV/EBITDA (TTM) | n/m | TTM EBITDA −HK$4.1m |
EV/Sales (TTM) | 38.3x | Revenue is mostly intra-group interest |
P/B | 0.09x | Book value per share HK$4.09 (S&P) / HK$4.1 (company) |
P/FCF (TTM) | 21.6x | FCF HK$35.1m |
Discount to NAV (derived) | approx. 91% | HK$0.38 vs HK$4.1 |
Market cap / LAAPL carrying value (derived) | approx. 9% | 759 / 8,145 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (HK cents, S&P rounded) | 1.3 | 1.0 | 1.0 | 0 | 0 |
Dividends paid in cash (HKD Mn) | 34.97 | 44.96 | 0 | 19.98 | 0 |
Buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Analyst Conclusions
Management guidance
Management gives no quantitative guidance. The 1H2026 prospects statement says the Group and its joint ventures will continue to manage their businesses, monitor their assets cautiously and exercise prudent capital management. It notes the upgraded Singapore forecast, slowing Mainland growth and rising downside risks from the Middle East conflict (1H2026 IR). No consensus forecasts exist.
Bull case
-
Extreme asset backing. NAV is HK$4.1 per share against a HK$0.38 price, and HKC-level gearing is only 6.2%. Even after severe haircuts to LAAPL's HK$8.1bn carrying value, the equity is covered many times. Any event that bridges price to NAV is highly accretive.
-
Investee operating recovery. OUE's core operations are growing: 1H2026 revenue rose 5.3%, with stronger hospitality and lower interest costs at OUE REIT. GPI losses already reduced the GPI carrying value through repeated impairments (S$20m in FY2025 and S$47m in 1H2026). Once the GPI drag is exhausted, the equity-accounted line could flip positive, as it did in FY2021–FY2023 (+HK$651m, +HK$471m, +HK$175m).
-
Simplification and capital recycling. The Lippo Ltd delisting, the OUEH privatisation, the CPCA sale proposal, First REIT's deleveraging and HKC's re-domiciliation all point to active portfolio management. That could culminate in value crystallisation, whether through dividends or a holdco transaction.
Bear case
-
Structural NAV discount is rational. HKC has paid no dividend since the FY2023 final. Revenue is collapsing as JV interest is waived. Interest cover is below 1x. Minorities have no route to the underlying value, so the discount may persist indefinitely.
-
Earnings risk is not over. TTM losses are HK$1.66bn. GPI remains exposed to a Mainland property market the company itself describes as being in a prolonged structural correction. The UOB judgment shows that legacy liabilities can surprise on the downside: the award went from S$17.7m to S$76.1m.
-
Controller-driven exit risk. The controlling family has a record of taking subsidiaries private, with Lippo Ltd in 2025 and OUEH proposed in 2026. A take-private of HKC at a modest premium to a deeply discounted price, rather than at a fraction of NAV, is a plausible adverse outcome for minorities. This is an inference from precedent, not a disclosed plan.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| Completion of re-domiciliation to Hong Kong | 2H2026–1H2027 | Cost savings; any bye-law changes affecting minorities |
| OUEH privatisation scheme vote | 2H2026 | Completion; cash outlay at OUE |
| OUE REIT EGM on Crowne Plaza Changi divestment | 2H2026 | Price versus book; use of proceeds |
| First REIT Indonesia divestment completion | 2H2026 | OUE group deleveraging |
| GPI results and further OUE impairments | OUE FY2026 results (about Feb 2027) | Size of share-of-loss line; residual GPI carrying value |
| HKC FY2026 results | About March 2027 | Equity-accounted swing; any dividend resumption |
| Settlement of UOB judgment by associate | 2H2026 | Cash impact; any further appeal |
| Refinancing of HK$507m bank loans | — | Margin and tenor |
| Any holdco restructuring (HKC/LCR) | Unscheduled | Offer price versus NAV (unconfirmed) |
| Singapore hospitality trends | Quarterly | RevPAR; visitor arrivals after the −1.7% 1H2026 decline |
Concluding analyst verdict
Hongkong Chinese Limited is a listed shell around one consequential asset: a 50% joint-venture interest in LAAPL, which carries a derived 33.8% look-through stake in OUE Limited. It also lends roughly S$380 million to the same structure. Every material number in HKC's accounts follows from that one exposure. In FY2025 it accounted for 95% of assets and the dominant share of revenue, and it explains a HK$1.9 billion swing in attributable results between FY2021 and FY2024.
On balance-sheet metrics, the company looks unusually safe. Gearing is about 6%, the current ratio is near 4x, and there are no pledges at HKC level. On income metrics, it looks fragile. Recurring revenue fell 59% year on year in 1H2026 as JV interest was waived, interest cover is below one, and dividends have stopped.
The market resolves this tension by applying a discount of roughly 91% to reported NAV. That discount should not be read as mispricing alone. It reflects three things. First, look-through leverage at OUE and LAAPL is real, including share-backed facilities. Second, OUE's Chinese Mainland exposure keeps producing impairments: S$67 million on GPI over FY2025–1H2026, plus share-of-loss charges. Third, minorities have no control over the timing or form of any value realisation, and there is a family-controlled corporate framework with a demonstrated preference for privatisations.
Our synthesis is neutral-to-cautious on fundamentals, with asymmetric event optionality. The operating trajectory at OUE's Singapore core is improving: revenue is up, financing costs are down, and assets are being recycled. If GPI losses taper, the equity-accounted line could normalise in FY2027. Investors should nonetheless treat HKC as a special-situation holding company rather than a compounder. The key monitorables are, in order: OUE's GPI exposure, the associate's settlement of the S$76 million UOB judgment, HKC's refinancing terms, and any structural proposal from the controlling shareholder. A transaction priced with reference to NAV would be transformative. Without one, the discount is likely to persist and returns will depend on the Singapore real-estate cycle.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Age (FY2025 AR) | Prior / concurrent roles | Education |
|---|---|---|---|---|---|
Dr. Stephen Riady | Chairman; Executive Director; Executive President since Jan 2015 | Director since Sep 1992 | 65 | Chairman and ED of Lippo China Resources (LCR); Executive Chairman and Group CEO of OUE; director of Lippo Capital Group / Holdings / Capital; resigned as Lippo Ltd director Jan 2026 | Graduate of University of Southern California; MBA, Golden Gate University; Hon. DBA, Edinburgh Napier University; Hon. University Fellow, HKBU (2006) |
Mr. John Luen Wai Lee, BBS, JP | Deputy Chairman (CEO until 7 Jun 2024); Executive Director | Director since Sep 1992 | 77 | Deputy Chairman, LCR; INED of New World Development and UMP Healthcare; director of Lippo and Hennessy; former Hospital Authority member; chaired Queen Elizabeth / HK Children's Hospital governing committees | FCA (ICAEW), FCCA, FCPA (HKICPA); Hon. Fellow, CityU |
Mr. Davy Kwok Fai Lee | Chief Executive Officer; Executive Director | Since Jun 2024 | 67 | CEO and ED of LCR; director of Lippo, Hennessy, Lippo Capital; 40+ years with the Lippo group; 30+ years in treasury, corporate administration and governance | BA (First Class), OUHK; MSc Investment Management, HKUST; JD, CUHK; DBA, PolyU; Fellow, CGI and HKCGI |
Mr. Brian Riady | Executive Director | Since Mar 2023 | 35 | Deputy CEO and ED of OUE; non-independent NED of OUE REIT Management; ED of LCR; resigned from Lippo board Jan 2026; son of Dr. Stephen Riady | BSc (Political Communication) and BA (Economics), UT Austin; Harvard Business School executive education |
Mr. Leon Nim Leung Chan | Non-executive Director (INED until Sep 2004) | Director since Sep 1992 | 70 | Principal partner, Y.T. Chan & Co.; NED of LCR; INED of Midland Holdings; former member of Solicitors Disciplinary Tribunal (1993–2008) | Solicitor (HK 1980, England 1984, Victoria 1985) |
Mr. King Fai Tsui | INED; Chairman of Audit, Remuneration and Nomination Committees | Since Sep 2004 (over 9 years) | 76 | INED of Newton Resources; ex-Big Four (US and HK); resigned Lippo board Jan 2026 | MSc Accountancy and BBA (First Class), University of Houston; FCPA, CA ANZ, AICPA |
Mr. Edwin Neo | INED | Since Jan 2018 (also 1995–1998) | 76 | Senior partner, Hoosenally & Neo; notary public; INED of LCR | LLB (Hons) and PCLL, HKU |
Ms. Min Yen Goh | INED | Since Dec 2022 | 65 | Managing director, Eng Wah Group; independent director of OUE; INED of LCR; resigned Lippo board Jan 2026 | BSc Economics and Finance (High Distinction), Babson College |
Ms. Millie Yuen Fun Luk | Company Secretary | — | — | — | — |
Governance Overview
| Item | Amount (HKD) | Source |
|---|---|---|
Director's fee per director (12-month basis, FY2025) | 282,000 (raised from 274,800 to 284,400 p.a. from 1 Apr 2025) | FY2025 AR |
Committee chairman fee (NEDs) | 93,900 | FY2025 AR |
Committee member fee (NEDs) | 60,600 | FY2025 AR |
Discretionary bonus — Dr. Stephen Riady | 3,087,150 | FY2025 AR |
Discretionary bonus — Mr. Davy Kwok Fai Lee | 1,036,400 | FY2025 AR |
Total Group staff costs incl. directors (FY2025) | approx. 18,000,000 (FY2024: 11,000,000) | FY2025 AR |
Directors' Remuneration
| Attribute | Detail |
|---|---|
Board size | 8: 4 executive, 1 non-executive, 3 INEDs |
Independence | 3/8 = 37.5% INEDs, above the one-third Listing Rule floor |
Chair/CEO separation | Yes. Chairman Dr. Stephen Riady; CEO Mr. Davy Kwok Fai Lee; roles set out in writing |
Gender diversity | 1 female director (12.5%) |
Audit Committee | Tsui (Chair), Chan, Neo. All non-executive; 3 meetings in FY2025 |
Remuneration Committee | Tsui (Chair), S. Riady, Chan, Neo, Goh. 3 meetings |
Nomination Committee | Tsui (Chair), S. Riady, Chan, Neo, Goh. 3 meetings |
Board meetings FY2025 |
|
CG Code deviation | Chairman did not attend the 23 Jun 2025 AGM (travelling overseas); Deputy Chairman presided |
Long-tenure INED | Mr. Tsui (since 2004); board affirmed independence |
Related-party overlap | All directors except Mr. Tsui also sit on the LCR board, a fellow subsidiary engaged in property investment and development |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
7 Jun 2024 | Davy Kwok Fai Lee appointed CEO and ED; John Lee re-designated Deputy Chairman | Succession within Lippo management bench |
Jan 2025 / Mar 2025 / Jan 2026 | Renewal of letter agreements (two-year terms) for S. Riady, J. Lee, B. Riady, L. Chan, E. Neo | Routine |
Jan 2026 | S. Riady, B. Riady, L. Chan, K.F. Tsui and M.Y. Goh resigned as directors of Lippo Limited | Follows Lippo Ltd privatisation in Sep 2025 |
Jun 2026 AGM | S. Riady, E. Neo, J. Lee retire by rotation and offer themselves for re-election. | FY2025 AR; etnet filing list |
Major Shareholders
| Holder | Shares | % | Notes |
|---|---|---|---|
Lippo Capital Limited (aggregate) | 1,179,199,264 | 59.01 | Direct 894,916,529 plus indirect 284,282,735 |
— of which Hennessy Holdings (via Lippo Limited) | 284,282,735 | 14.23 | Counted within the 59.01% |
Mr. John Luen Wai Lee (personal and family) | 4,496,165 | 0.23 | — |
Mr. King Fai Tsui (personal and family) | 675,000 | 0.03 | — |
Mr. Davy Kwok Fai Lee | 932 | 0.00 | — |
Institutions (aggregate) | — | approx. 0.32 | S&P GMI via StockAnalysis |
Free float (S&P) | approx. 813.9m | approx. 40.7 | — |
Competitive Landscape
Competitor Detail
| Layer | Competitor / comparable | Listing | Relevance |
|---|---|---|---|
Sister / holding-company comparable | Lippo China Resources Limited | HKEX 0156 | Same controller, overlapping board, property investment and development; competing-business disclosure in HKC AR |
HK holding companies with SE Asian property / hotels | Keck Seng Investments (Hong Kong) | HKEX 0184 | Hotels and property in Asia/US |
| — | Shun Tak Holdings | HKEX 0242 | Property, hospitality, transport |
| — | Far East Consortium International | HKEX 0035 | Hotels (Dorsett), property; bought Oakwood Premier from OUE in 2019 |
| — | Wing Tai Properties | HKEX 0369 | HK property / hospitality |
| — | Hang Lung Group | HKEX 0010 | HK/Mainland property holdco (scale benchmark) |
Singapore real estate (OUE's arena) | City Developments; UOL Group; Frasers Property; CapitaLand Investment | SGX | Office, hospitality and residential competition |
Singapore office REITs (OUE REIT's arena) | Keppel REIT; CapitaLand Integrated Commercial Trust; Suntec REIT | SGX | Grade A CBD office leasing |
Healthcare (OUEH's arena) | IHH Healthcare; Raffles Medical Group | Bursa / SGX | Private healthcare in Singapore / China |
Peer Comparison FY2025
| Metric (FY2025) | Hongkong Chinese (0655) | OUE Limited (investee) | Keck Seng Investments (0184) | Shun Tak Holdings (0242) | Hang Lung Group (0010) |
|---|---|---|---|---|---|
Revenue | HK$53m | S$617.0m | — | — | Rental revenue HK$9,853m (−2%) |
Revenue growth | −27.0% | −4.6% | — | — | Overall revenue −11% |
Bottom line | Loss HK$892m | Loss S$279.1m | Profit HK$338.1m (FY2024: 353.5m) | Loss HK$462.6m (FY2024: 749.6m) | — |
Dividend | Nil | 2.0 Singapore cents | — | Nil (per results) | HK86 cents full-year |
R&D intensity | 0% | Not applicable | Not applicable | Not applicable | Not applicable |



